Watch Now

Coronavirus

Actions

FDA allows emergency use of antibody drug Trump received

FDA allows emergency use of antibody drug Trump received
Regeneron
AP
In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, scientists work with a bioreactor at a company facility in New York state, for efforts on an experimental coronavirus antibody drug. The Food and Drug Administration on Saturday, Nov. 21, 2020 authorized the use of the Regeneron Pharmaceuticals Inc. drug to try to prevent patients with mild-to-moderate disease from worsening and needing hospitalization. It's given as a one-time treatment through an IV and is still going through more testing to establish its safety and effectiveness. (Regeneron via AP)
FDA allows emergency use of antibody drug Trump received
Posted

U.S. health officials have allowed the emergency use of a second antibody drug to help the immune system fight COVID-19.

It's an experimental medicine that President Donald Trump was given when he was sickened last month.

The Food and Drug Administration on Saturday authorized use of the Regeneron Pharmaceuticals Inc. drug for people with mild-to-moderate symptoms.

Tests of the drug are continuing, but early results suggest it may prevent hospitalization and emergency room visits.

Use is allowed for adults and children 12 and over who are at high risk of severe illness from COVID-19 because of age or certain other medical conditions.

Copyright 2020 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
COVID-19 Vaccine

COVID-19 Vaccine

Click Above For COVID-19 Vaccine Information

Global Coronavirus Tracker:

See map here
Data from The Center for Systems Science and Engineering at Johns Hopkins University.